Table 1 Descriptive demographic data for the Multiple Sclerosis (MS) and Healthy Control groups
Multiple Sclerosis | Healthy Control | |
|---|---|---|
N | 35 | 32 |
Age (years) | 34.2 ± 10 (18–55) | 32.03 ± 8.40 |
Education (years) | 13.8 ± 3.5 (8–23) | 14.70 ± 3.42 |
Expanded Disability Status Scale (EDSS) score | 1.44 ± 1.4 (0–6) | – |
Average duration of disease (years) | 4.66 ± 4 (0.25–13.6) | – |
Average acute exacerbations (n) | 1.82 ± 0.5 (1–3) | – |
SEX | ||
Men (n) | 6 (17%) | 9 (28%) |
Women (n) | 29 (83%) | 23 (72%) |
Pharmacologic treatment | ||
Interferon-β 1a (n) | 16 (45.7%) | – |
Interferon-β 1b (n) | 8 (22.85%) | – |
Glatiramer acetate (n) | 3 (8.6%) | – |
Natalizumabe (n) | 2 (5.7%) | – |
None (n) | 6 (17.15%) | 32 (100%) |
Physical activity | ||
Exercised (n) | 9 (25.7%) | 12 (37.5%) |
Sedentary (n) | 26 (74.3%) | 20 (62.5%) |
Employment status | ||
Yes (n) | 28 (80%) | 32 (100%) |
No (n) | 7 (20%) | 0 (0%) |